PETA protests against Charles River at Biotech Week Boston

By Dan Stanton contact

- Last updated on GMT

Related tags: Charles river

Campaigning group People for the Ethical Treatment of Animals (PETA) picketed a conference in Boston on Tuesday to protest the use of animals in drug research and development.

A ‘mutilated rabbit’ stood outside the Sheraton Hotel in Back Bay, Boston as part of a protest led by animal welfare group PETA against Charles River Laboratories, sponsor of the inaugural World Congress on Animal Models in Drug Discovery & Development in Boston on Tuesday.

The conference – part of Biotech Week Boston – aimed to discuss the application of traditional and non-traditional animal models, and novel in vitro​ and ex vivo​ approaches to disease modelling and drug discovery.

However, the animal welfare group claims researchers should switch to modern, non-animal based methods and accused Charles River of “using this conference to peddle its services.”

PETA chief of Laboratory Case Management Alka Chandna said: “PETA is calling on scientists at the conference to get out of the Dark Ages, admit animal studies don’t work, and commit to using in vitro testing, human organs-on-chips, and other modern research methods.”

Charles River said its work with animal-based models is both essential for discovering and developing drugs and required by the US Food and Drug Administration (FDA).

The survival rates for major diseases are at an all-time high thanks to the discovery of new drugs,” ​the contract research organization (CRO) said in a statement sent to Biopharma-Reporter. “Our work is an essential component of the research that has led to these discoveries and is required by the FDA. Charles River has played a vital role in virtually every medical advance for humans as well as animals.”

The CRO added: Charles River has a deep commitment to animal welfare and we make every effort to exceed national standards for the care of the research models under our stewardship.”

Related products

show more

Rapid Biosafety Testing Enables the Future of Manufacturing

Rapid Biosafety Testing Enables the Future of Manufacturing

Viral Safety for mAb: Prevent, Detect, Remove | 05-Aug-2020 | Technical / White Paper

Traditional methods for adventitious agent testing rely on biological amplification and detection, which can take several weeks. This time-consuming approach...

Related suppliers

Follow us

Products

View more

Webinars